We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Liquid Rhinoplasty Offers a Non-Surgical Cosmetic Alternative

By HospiMedica International staff writers
Posted on 12 Mar 2020
Nonsurgical rhinoplasty using dermal fillers is a safe procedure with positive aesthetic results when performed by an experienced clinician, claims a new study.

Ayad Harb, FRCSPlast, a consultant plastic surgeon and world authority on liquid rhinoplasty, and Colin Brewster, MRes, of Queen Elizabeth Hospital (Gateshead, United Kingdom), conducted a study of nonsurgical rhinoplasty in 5,000 patients (mean age 27 years, mostly female), who were treated between March 2016 and January 2019 by Dr. More...
Harb. Study parameters included patient demographics, indications, treatment details, and outcomes. Average procedure time was 12 minutes, with the average filler injected about 0.72 mL.

The most common patient complaint was a dorsal hump (44%), with about 20% of patients seeking to refine the results after a previous rhinoplasty surgery. Liquid rhinoplasty was also used to treat other patient concerns, such as drooping nasal tip (15%), lack of definition (almost nine percent), frontal asymmetry (seven percent) and bulbous tip (six percent). Hyaluronic acid was the preferred filler due to its reversibility in the event of vascular occlusion. Another benefit is that it can be pre-mixed with local anesthetic, avoiding the need for pre-procedural local anesthetic, which can distort or mask subtle deformities.

The results showed that erythema and swelling were a common observation in the first five days, but generally settled with time; other complications were infrequent. A small number of patients (0.5%) showed signs of vascular occlusion; in most cases, blood flow was restored with simple measures. If not, a hyaluronidase enzyme injection was performed to immediately dissolve the dermal filler. The results lasted for 9-12 months, with approximately 32% returning at 12 months, most of whom were treated again. The study was published the March 2020 issue of Plastic and Reconstructive Surgery.

“The injections are carried out at the radix and move caudally with a micro-droplet technique of boluses of no more than 0.1 mL at any one point. Frequently, and especially nearer the tip, deposits of filler can be as small as 0.02 mL,” concluded Dr. Harb. “With each injection point, the gel implant is massaged into place and can be maneuverer to produce a smooth and symmetrical surface. The injections continue in the midline until the tip is reached; the tip is injected perpendicular to the skin to improve projection and definition.”

Nonsurgical rhinoplasty with injectable dermal fillers has become an increasingly popular alternative to surgical procedures, in view of its relative low cost, convenience and rapid recovery, and low risk profile. Although the procedure is not intended to replace surgical rhinoplasty, it has proven beneficial in discrete cases of inadequate tip projection, dorsal hump, and low radix. Nonsurgical rhinoplasty has also been used to improve functionality of the nose by splinting the nasal valves.


Related Links:
Queen Elizabeth Hospital


Gold Member
12-Channel ECG
CM1200B
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Pressure Transducer
TruWave
New
Complete Hip System
Taperloc Complete Hip System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.